androstenediol has been researched along with etiocholanolone in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chapman, D; Jain, AN; Koile, K | 1 |
| Good, AC; Richards, WG; So, SS | 1 |
| Platt, DE; Silverman, BD | 1 |
| Karplus, M; So, SS | 1 |
| Hamprecht, FA; Kubinyi, H; Mietzner, T | 1 |
| Strassburg, CP; Tukey, RH | 1 |
| Clementi, S; Cruciani, G; McLay, I; Pastor, M; Pickett, S | 1 |
| Baumann, K; Stiefl, N | 1 |
| Higashiura, K; Kotani, T | 1 |
| Ban, F; Cherkasov, A; Fallahi, M; Hammond, GL; Santos-Filho, O; Thorsteinson, N | 1 |
| Borg, B; Granneman, J; Lambert, J; Mayer, I; Schulz, R | 1 |
| Hendricks, TS; Johnson, AR; Milewich, L | 1 |
| Cardounel, A; Kalimi, M; Regelson, W | 1 |
| Sharifi, N | 1 |
2 review(s) available for androstenediol and etiocholanolone
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Clinical implications of the 5α-androstanedione pathway for castration-resistant prostate cancer.
Topics: 3-Hydroxysteroid Dehydrogenases; Abiraterone Acetate; Androstadienes; Androstenediol; Antineoplastic Agents; Dehydroepiandrosterone; Etiocholanolone; Humans; Male; Orchiectomy; Prostatic Neoplasms; Receptors, Androgen; Testosterone | 2011 |
12 other study(ies) available for androstenediol and etiocholanolone
| Article | Year |
|---|---|
Compass: predicting biological activities from molecular surface properties. Performance comparisons on a steroid benchmark.
Topics: Algorithms; Models, Molecular; Models, Statistical; Molecular Conformation; Sex Hormone-Binding Globulin; Steroids; Structure-Activity Relationship; Surface Properties; Transcortin | 1994 |
Structure-activity relationships from molecular similarity matrices.
Topics: Computer Simulation; Electrochemistry; Models, Molecular; Molecular Structure; Neural Networks, Computer; Sex Hormone-Binding Globulin; Steroids; Structure-Activity Relationship; Transcortin | 1993 |
Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition.
Topics: Adrenal Cortex Hormones; Binding Sites; Mathematics; Models, Molecular; Molecular Conformation; Molecular Structure; Molecular Weight; Predictive Value of Tests; Steroids; Structure-Activity Relationship; Testosterone | 1996 |
Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 1. Method and validations.
Topics: Algorithms; Models, Chemical; Molecular Structure; Neural Networks, Computer; Protein Binding; Static Electricity; Steroids; Structure-Activity Relationship; Transcortin | 1997 |
Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices.
Topics: Drug Design; Least-Squares Analysis; Molecular Conformation; Steroids; Structure-Activity Relationship; Transcortin | 1998 |
GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors.
Topics: Butyrophenones; Enzyme Inhibitors; Glucose; Models, Molecular; Phosphorylases; Protein Binding; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Software; Steroids; Transcortin | 2000 |
Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique.
Topics: Acetates; Alcohols; Algorithms; Cholinergic Agents; Hydrocarbons, Acyclic; Hydrocarbons, Aromatic; Ketones; Models, Molecular; Protein Binding; Quantitative Structure-Activity Relationship; Receptor, Muscarinic M2; Receptors, Muscarinic; Steroids; Transcortin | 2003 |
Comparative molecular active site analysis (CoMASA). 1. An approach to rapid evaluation of 3D QSAR.
Topics: Binding Sites; Cluster Analysis; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Isoenzymes; Models, Molecular; Prostaglandin-Endoperoxide Synthases; Quantitative Structure-Activity Relationship; Steroids | 2004 |
An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.
Topics: Binding Sites; Binding, Competitive; Computer Simulation; Databases as Topic; Humans; Ligands; Linear Models; Models, Molecular; Predictive Value of Tests; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Sex Hormone-Binding Globulin; Steroids | 2008 |
Metabolism of androstenedione and 11-ketotestosterone in the kidney of the three-spined stickleback, Gasterosteus aculeatus.
Topics: Androstane-3,17-diol; Androstenediol; Androstenedione; Androstenes; Animals; Etiocholanolone; Female; Fishes; Glucuronates; Kidney; Male; Testosterone | 1992 |
Metabolism of dehydroisoandrosterone and androstenedione in human pulmonary endothelial cells in culture.
Topics: Androstenediol; Androstenedione; Androsterone; Cells, Cultured; Dehydroepiandrosterone; Dihydrotestosterone; Endothelium; Etiocholanolone; Humans; Male; Pulmonary Artery; Pulmonary Veins; Testosterone | 1983 |
Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action.
Topics: Amyloid beta-Protein Precursor; Androstenediol; Androstenedione; Animals; Cell Survival; Clone Cells; Dehydroepiandrosterone; Etiocholanolone; Glutamic Acid; Hippocampus; Mice; Neurons; Neuroprotective Agents; Neurotoxins; Testosterone | 1999 |